Welcome to the 21st WCP Virtual Congress Program Scheduling
The congress will officially run on Colombian Standard Time (UTC-5)
To convert the congress times to your local time Click Here
Filter - Live Sessions: Plenary / Presidential Session | Courses | Special Sessions | Presidential Forum | Spanish Language Sessions | State of the Art Sessions | Interorganizational Symposia | Original Sessions | Panel Discussions | Thematic Sessions
Filter - Recorded Sessions: Accepted Symposia | Free Communications | WPA Distinguished Lectures
Industry Hall I
This session will begin with Professor Guy Goodwin exploring the history of psychedelics, examining how academic research in the 20th Century heralded the promise of an exciting new therapy for many mental health conditions, before political and moral panic led to a shutdown of research. It will look at how, after a hiatus of several decades, psychedelics are now enjoying a renaissance with new studies once again showing the promise of psychedelic therapy and its potential use in psychiatry. Dr Metten Somers will give a first-hand account of setting up and running a psilocybin therapy trial for treatment-resistant depression, as part of a large-scale phase IIb clinical study that completed recruitment during the COVID-19 pandemic.
Realising the promise of psychedelic therapy for treatment-resistant depression.
Supported by COMPASS Pathways
Can we successfully re-medicalise psychedelics?
- Guy Goodwin (United Kingdom)
The safety and efficacy of psilocybin in treatment resistant depression
- Metten Somers (Netherlands)
- All Faculty